Self-tolerance of natural killer cells

Nature Reviews Immunology

Volumn 6, Issue 7, 2006, Pages 520-531

  Raulet, David H ^a   Vance, Russell E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BROXURIDINE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD11B ANTIGEN; CD94 ANTIGEN; CONCANAVALIN A; FC RECEPTOR; GAMMA INTERFERON; IONOMYCIN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL LECTIN LIKE RECEPTOR G1; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 1; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR SUBFAMILY B MEMBER 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAST CELL FUNCTION ASSOCIATED ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PHORBOL ESTER; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CLONAL ANERGY; CYTOKINE PRODUCTION; GENETIC VARIABILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNORECEPTOR TYROSINE BASED INHIBITORY MOTIF; LISTERIA MONOCYTOGENES; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; SYSTEMATIC REVIEW; T LYMPHOCYTE; TRANSGENE; VIRUS INFECTION;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE;

EID: 33745567831     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1863     Document Type: Review

References (103)

1. Raulet, D. H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunol. 5, 996-1002 (2004).
2. Herberman, R. B., Nunn, M. E. & Lavrin, D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16, 216-229 (1975).
3. Kiessling, R., Klein, E. & Wigzell, H. 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112-117 (1975).
4. Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K. & Welsh, R. M. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1531-1538 (1983).
5. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999).
6. Diefenbach, A. & Raulet, D. H. The innate immune response to tumors and its role in the induction of T cell immunity. Immunol. Rev. 188, 9-21 (2002).
7. Yu, Y. Y. L., Kumar, V. & Bennett, M. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10, 189-213 (1992).
8. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 47, 187-376 (1989).
9. H1 priming. Nature Immunol. 5, 1260-1265 (2004).
10. Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
11. Raulet, D. H., Vance, R. E. & McMahon, C. W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19, 291-330 (2001).
12. Moretta, A. et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223 (2001).
13. Fernandez, N. C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423 (2005). This report was the first to show in normal animals the existence of self-tolerant NK cells that lack inhibitory receptors specific for self MHC class I molecules, as well as to show that these NK cells (similar to all NK cells from MHC-class-I-deficient mice) show dampened responses to stimulatory ligands and tumour cells.
14. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005). This paper reports that NK cells that lack receptors for self MHC class I molecules are functionally defective, and the authors propose that the engagement of self MHC class I molecules by inhibitory receptors on developing NK cells is required for the functional maturation ('licensing') of NK cells.
15. Valiante, N. et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751 (1997). This paper examines the inhibitory and stimulatory receptors expressed by each NK-cell clone in panels of NK-cell clones from two individuals with different HLA haplotypes. Each clone in a given panel expressed at least one inhibitory receptor specific for the HLA class I molecules of the donor.
16. Kubota, A., Kubota, S., Lohwasser, S., Mager, D. L. & Takei, F. Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163, 212-216 (1999).
17. Raulet, D. H. et al. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155, 41-52 (1997).
18. Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678 (1986).
19. b mice.
20. Bix, M. et al. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice. Nature 349, 329-331 (1991).
21. Liao, N., Bix, M., Zijlstra, M., Jaenisch, R. & Raulet, D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199-202 (1991).
22. 2 m-deficient mice) and that, despite the absence of MHC-class-I-specific inhibitory molecules, these NK cells are self-tolerant. In addition, these NK cells show impaired killing of certain tumour target cells and fail to reject allogeneic bone-marrow cells.
23. - and TAP-1-mice. J. Immunol. 159, 5219-5225 (1997).
24. Grigoriadou, K., Menard, C., Perarnau, B. & Lemonnier, F. A. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur. J. Immunol. 29, 3683-3690 (1999).
25. Oberg, L. et al. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur. J. Immunol. 34, 1646-1653 (2004).
26. George, T. C., Ortaldo, J. R., Lemieux, S., Kumar, V. & Bennett, M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J. Immunol. 163, 1859-1867 (1999).
27. 1-hybrid BALB/c x C57BL/6 mice depends on the expression of retinoic acid early transcript 1 (RAE1; which is a ligand for the stimulatory receptor NKG2D) by the bone-marrow cells. This is one of only two studies in which investigators have defined stimulatory ligands that are involved in recognition of normal cell types by NK cells.
28. Yokoyama, W. M. & Plougastel, B. F. Immune functions encoded by the natural killer gene complex. Nature Rev. Immunol. 3, 304-316 (2003).
29. Held, W., Dorfman, J. R., Wu, M.-F. & Raulet, D. H. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26, 2286-2292 (1996).
30. Dorfman, J. R. & Raulet, D. H. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187, 609-618 (1998).
31. Roth, C., Carlyle, J. R., Takizawa, H. & Raulet, D. H. Clonal acquisition of inhibitory Ly49 receptors on differentiating NK cell precursors is successively restricted and regulated by stromal cell class I MHC. Immunity 13, 143-153 (2000).
32. Sivori, S. et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA 99, 4526-4531 (2002).
33. McNerney, M. E., Guzior, D. & Kumar, V. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK cell self-tolerance in mice. Blood 106, 1337-1340 (2005). Using mice with mutations in CD48, which is a ligand for the receptor 2B4, this paper shows that 2B4 provides a potent inhibitory signal to NK cells. The possibility that this inhibitory interaction has a role in NK-cell self-tolerance is discussed.
34. Markel, G. et al. Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur. J. Immunol. 34, 2138-2148 (2004).
35. Wu, M.-F. & Raulet, D. H. Class I-deficient hematopoietic cells and non-hematopoietic cells dominantly induce unresponsiveness of NK cells to class I-deficient bone marrow grafts. J. Immunol. 158, 1628-1633 (1997). In this paper, fetal liver chimeras were studied in which mixtures of normal and MHC-class-I-deficient haematopoietic cells differentiated in either MHC-class-1-expressing or MHC-class-I-deficient hosts. The results show that body cells that lack expression of MHC class I molecules dominantly induce tolerance of NK cells, despite the presence of cells that do express MHC class I molecules.
36. Ljunggren, H.-G., Van Kaer, L., Ploegh, H. L. & Tonegawa, S. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc. Natl Acad. Sci. USA 91, 6520-6524 (1994).
37. Zimmer, J. et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187, 117-122 (1998).
38. Furukawa, H. et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum. Immunol. 60, 32-40 (1999).
39. Yokoyama, W. M. & Kim, S. How do natural killer cells find self to achieve tolerance? Immunity 24, 249-257 (2006).
40. Lanzavecchia, A. Licence to kill. Nature 393, 413-414 (1998).
41. MacDonald, H. R. NK cell tolerance: revisiting the central dogma. Nature Immunol. 6, 868-869 (2005).
42. Hanke, T., Takizawa, H. & Raulet, D. H. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur. J. Immunol. 31, 3370-3379 (2001).
43. Vance, R. E., Jamieson, A. M., Cado, D. & Raulet, D. H. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc. Natl Acad. Sci. USA 99, 868-873 (2002).
44. Lowin-Kropf, B., Kunz, B., Beermann, F. & Held, W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J. Immunol. 165, 1314-1321 (2000).
45. d) transgene in a mosaic manner (that is, at the surface of some cells but not others) were examined. The results show that body cells that lack an MHC class I molecule dominantly induce tolerance of NK cells, despite the presence of cells that do express MHC class I molecules.
46. Held, W. & Raulet, D. H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in NK cell development. J. Exp. Med. 185, 2079-2088 (1997).
47. Shilling, H. G. et al. Genetic control of human NK cell repertoire. J. Immunol. 169, 239-247 (2002).
48. + multipotent marrow progenitor cells. J. Immunol. 163, 2648-2656 (1999).
49. Iizuka, K., Naidenko, O. V., Plougastel, B. F., Fremont, D. H. & Yokoyama, W. M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nature Immunol. 4, 801-807 (2003).
50. Carlyle, J. R. et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl Acad. Sci. USA 101, 3527-3532 (2004).
51. Corral, L., Hanke, T., Vance, R. E., Cado, D. & Raulet, D. H. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur. J. Immunol. 30, 920-930 (2000).
52. Roncagalli, R. et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nature Immunol. 6, 1002-1010 (2005).
53. Parolini, S. et al. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346 (2000).
54. Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932-2936 (2000).
55. Kumar, V. & McNerney, M. E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nature Rev. Immunol. 5, 363-374 (2005).
56. Glynne, R. et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403, 672-676 (2000).
57. Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305-334 (2003).
58. Olcese, L. et al. Human and mouse killer-cell inhibitory receptors recruit Ptplc and Ptpld protein tyrosine phosphatases. J. Immunol. 156, 4531-4534 (1996).
59. Long, E. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904 (1999).
60. Jamieson, A. M., Isnard, P., Dorfman, J. R., Coles, M. C. & Raulet, D. H. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172, 864-870 (2004).
61. d-negative leukaemia. Scand. J. Immunol. 59, 71-78 (2004).
62. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202, 1075-1085 (2005).
63. Reg cells can inhibit the function of NK cells, raising the possibility that such T cells might have a role in NK-cell self-tolerance.
64. 2-microglobulin. Eur. J. Immunol. 27, 342-345 (1997).
65. b heavy chains. Eur. J. Immunol. 28, 370-378 (1998).
66. 2-microglobulin-deficient mice. J. Immunol. 154, 780-789 (1995).
67. Johansson, S. et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201, 1145-1155 (2005).
68. Poirot, L., Benoist, C. & Mathis, D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl Acad. Sci. USA 101, 8102-8107 (2004).
69. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
70. Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391, 795-799 (1998).
71. b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190, 1801-1812 (1999).
72. b. J. Exp. Med. 188, 1841-1848 (1998).
73. + IL-2 activated natural killer cells. Nature 358, 66-70 (1992).
74. Karlhofer, F. M., Hunziker, R., Reichlin, A., Margulies, D. H. & Yokoyama, W. M. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J. Immunol. 153, 2407-2416 (1994).
75. Hanke, T. et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11, 67-77 (1999).
76. Colonna, M. et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc. Natl Acad. Sci. USA 89, 7983-7985 (1992).
77. Colonna, M. et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818 (1997).
78. Cosman, D. et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282 (1997).
79. Raulet, D. H. Roles of the NKG2D immunoreceptor and its ligands. Nature Rev. Immunol. 3, 781-790 (2003).
80. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
81. Diefenbach, A., Hsia, J. K., Hsiung, M. Y. & Raulet, D. H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33, 381-391 (2003).
82. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
83. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133 (2001).
84. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. The DNA damage pathway regulates innate immune system ligands for the NKG2D receptor. Nature 436, 1186-1190 (2005).
85. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
86. Brown, M. G. et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934-937 (2001).
87. Daniels, K. A. et al. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194, 29-44 (2001).
88. Lee, S. H. et al. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197, 515-526 (2003).
89. Smith, H. R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl Acad. Sci. USA 99, 8826-8831 (2002).
90. George, T. C., Mason, L. H., Ortaldo, J. R., Kumar, V. & Bennett, M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162, 2035-2043 (1999).
91. d target cells leads to Dap-12 phosphorylation and IFN-γ secretion. J. Immunol. 164, 603-611 (2000).
92. d and activates natural killer cell cytotoxicity. J. Exp. Med. 189, 493-500 (1999).
93. Ravetch, J. V. & Kinet, J.-P. Fc receptors. Annu. Rev. Immunol. 9, 457-492 (1991).
94. Pende, D. et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516 (1999).
95. Arnon, T. I. et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nature Immunol. 6, 515-523 (2005).
96. Vitale, M. et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065-2072 (1998).
97. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001).
98. Pessino, A. et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188, 953-960 (1998).
99. Brown, M. H. et al. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188, 2083-2090 (1998).
100. Bottino, C. et al. Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198, 557-567 (2003).
101. Hanke, T., Corral, L., Vance, R. E. & Raulet, D. H. 2F1 antigen, the mouse homolog of the rat 'mast cell function-associated antigen', is a lectin like type II transmembrane receptor expressed by natural killer cells. Eur. J. Immunol. 28, 4409-4417 (1999).
102. Ito, M. et al. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J. Exp. Med. 203, 289-295 (2006).
103. Grundemann, C. et al. Identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J. Immunol. 176, 1311-1315 (2006).